 |
|
Home | GlaxoSmithKline plc Receives Consensus Rating of “Hold” from Analysts (NYSE:GSK) |
 |
GlaxoSmithKline plc Receives Consensus Rating of “Hold” from Analysts (NYSE:GSK)
|
 |
- August 29, 2014
-
GlaxoSmithKline plc (NYSE:GSK) has been given an average rating of “Hold” by the twenty brokerages that are currently covering the stock, AmericanBankingNews.com reports. Three analysts have rated the stock with a sell recommendation, twelve have issued a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target price among […]This article (GlaxoSmithKline plc Receives Consensus Rating of “Hold” from Analysts (NYSE:GSK)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2014/08/29/glaxosmithkline-plc-receives-consensus-rating-of-hold-from-analysts-nysegsk-2/
|
 |
|
 |
|
 |
